UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000034606
Receipt number R000039450
Scientific Title The effects of novel chocolate on postprandial blood glucose level in healthy adults
Date of disclosure of the study information 2018/12/24
Last modified on 2019/08/14 13:11:13

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effects of novel chocolate on postprandial blood glucose level in healthy adults

Acronym

The effects of dietary novel chocolate on postprandial blood glucose

Scientific Title

The effects of novel chocolate on postprandial blood glucose level in healthy adults

Scientific Title:Acronym

The effects of dietary novel chocolate on postprandial blood glucose

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We randomly allocated twelve subjects to administer any of the novel chocolate, the control chocolate, and the sugar to investigate the postprandial blood glucose level, followed by a washout period. These subjects were then crossed over and received the alternative chocolate.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Blood glucose level, the blood glucose areas under the curve (AUC), the maximum blood glucose level(Cmax) , and time to reach Cmax(Tmax)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Placebo

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking

YES

Concealment

Pseudo-randomization


Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Single dose administration of 65 g of the novel chocolate in intervention period

Interventions/Control_2

Single dose administration of 65 g of the control chocolate in control period

Interventions/Control_3

Single dose administration of 19.2 g of sugars in sugars period

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

29 years-old >=

Gender

Male and Female

Key inclusion criteria

1) All subjects voluntarily signed the informed consent after detailed description and understanding of this study
2) Those who belong to a particular university.
3) Subjects with fasting blood glucose level within normal range between 70 mg/dL and 110 mg/dL using the first blood test
4) Subjects with systolic blood pressure under 140 mmHg and diastolic blood pressure under 90 mm Hg
5) Subjects with BMI above 18.5 kg/ m2-under 30 kg/ m2
6) Females who have a regular menstrual cycle, which is 25 to 38 days, and at the first test, who are from 14 days after the start of their menstruation to the next menstruation.
7) Non-smokers

Key exclusion criteria

1) Those who administer ''Food for Specified Health Use'', ''Foods with Function Claims'' or medicine to have effects on blood glucose metabolism.
2) Patients with diseases undergoing treatments or with medical history of severe diseases.
3) Patients who have severe diseases: diabetes, liver disease, kidney disease, heart disease (or persons who have history of these diseases).
4) Those who may suffer from allergy by administering milk, soybean, or cacao mass (chocolate).
5) Subjects who are in pregnancy, lactation.
6) Those who were included other clinical trials within one month before giving written informed consent, or during this study.
7) Any other medical and/or health reasons unfavorable to participation in this study, as judged by the principal investigator or examination doctor.

Target sample size

12


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Professor Toshihiro Miura

Organization

Suzuka University of Medical Science

Division name

Faculty of Health Science

Zip code


Address

1001-1, Kishioka, Suzuka-city, Mie, 510-0293

TEL

059-383-8991

Email

miura@suzuka-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Midori Natsume

Organization

Meiji Co., Ltd.

Division name

Group2, Food Science & Technology Research Laboratories, R&D Division

Zip code


Address

1-29-1 Nanakuni, Hachiouji, Tokyo 192-0919

TEL

042-632-5850

Homepage URL


Email

midori.natsume@meiji.com


Sponsor or person

Institute

Suzuka University of Medical Science

Institute

Department

Personal name



Funding Source

Organization

Meiji Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

鈴鹿医療科学大学(三重県)


Other administrative information

Date of disclosure of the study information

2018 Year 12 Month 24 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled

11

Results

1) Analysis of all subjects revealed no significant difference between the control and test diets.

2) The test diet showed significant decrease in incremental area under the curve when compared with sucrose only while control diet did not change.

3) Compared to sucrose only, the chocolate with or without fructooligosaccharides significantly decreased blood glucose and Cmax.

Results date posted

2019 Year 08 Month 14 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results

2019 Year 03 Month 30 Day

Baseline Characteristics


Participant flow


Adverse events

None

Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 10 Month 19 Day

Date of IRB


Anticipated trial start date

2018 Year 11 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 10 Month 23 Day

Last modified on

2019 Year 08 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039450


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name